CIBC Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $188M | Buy |
747,319
+47,137
| +7% | +$10.1M | 0.41% | 51 |
|
|
2026
Q1 | $152M | Buy |
700,182
+12,103
| +2% | +$2.68M | 0.37% | 53 |
|
|
2025
Q4 | $157M | Buy |
688,079
+367,172
| +114% | +$83.6M | 0.38% | 51 |
|
|
2025
Q3 | $74.3M | Buy |
320,907
+2,466
| +0.8% | +$502K | 0.22% | 79 |
|
|
2025
Q2 | $59.1M | Sell |
318,441
-16,877
| -5% | -$3.14M | 0.18% | 92 |
|
|
2025
Q1 | $70.2M | Buy |
335,318
+512
| +0.2% | +$99.5K | 0.23% | 80 |
|
|
2024
Q4 | $59.5M | Sell |
334,806
-27,536
| -8% | -$5.06M | 0.2% | 87 |
|
|
2024
Q3 | $71.5M | Buy |
362,342
+20,137
| +6% | +$3.76M | 0.23% | 78 |
|
|
2024
Q2 | $58.7M | Sell |
342,205
-10,903
| -3% | -$1.81M | 0.21% | 81 |
|
|
2024
Q1 | $64.3M | Sell |
353,108
-2,627
| -0.7% | -$453K | 0.22% | 83 |
|
|
2023
Q4 | $55.1M | Sell |
355,735
-14,138
| -4% | -$2.06M | 0.21% | 84 |
|
|
2023
Q3 | $55.1M | Sell |
369,873
-6,772
| -2% | -$994K | 0.23% | 81 |
|
|
2023
Q2 | $50.7M | Sell |
376,645
-11,132
| -3% | -$1.63M | 0.19% | 93 |
|
|
2023
Q1 | $61.8M | Buy |
387,777
+2,339
| +0.6% | +$358K | 0.25% | 75 |
|
|
2022
Q4 | $62.3M | Sell |
385,438
-2,719
| -0.7% | -$417K | 0.26% | 74 |
|
|
2022
Q3 | $52.1M | Buy |
388,157
+86,255
| +29% | +$12.4M | 0.23% | 76 |
|
|
2022
Q2 | $46.2M | Buy |
301,902
+5,546
| +2% | +$847K | 0.19% | 84 |
|
|
2022
Q1 | $48M | Buy |
296,356
+82,023
| +38% | +$11.9M | 0.17% | 85 |
|
|
2021
Q4 | $29M | Buy |
214,333
+3,830
| +2% | +$452K | 0.11% | 123 |
|
|
2021
Q3 | $22.7M | Buy |
210,503
+3,612
| +2% | +$413K | 0.09% | 141 |
|
|
2021
Q2 | $23.3M | Buy |
206,891
+5,932
| +3% | +$668K | 0.09% | 133 |
|
|
2021
Q1 | $21.7M | Sell |
200,959
-7,059
| -3% | -$755K | 0.09% | 133 |
|
|
2020
Q4 | $22.3M | Sell |
208,018
-389
| -0.2% | -$37.4K | 0.1% | 130 |
|
|
2020
Q3 | $18.3M | Sell |
208,407
-11,433
| -5% | -$1.08M | 0.09% | 133 |
|
|
2020
Q2 | $21.6M | Buy |
219,840
+4,255
| +2% | +$375K | 0.13% | 109 |
|
|
2020
Q1 | $16.4M | Sell |
215,585
-15,180
| -7% | -$1.29M | 0.12% | 117 |
|
|
2019
Q4 | $20.4M | Sell |
230,765
-22,751
| -9% | -$1.89M | 0.12% | 92 |
|
|
2019
Q3 | $19.2M | Buy |
253,516
+4,532
| +2% | +$311K | 0.11% | 92 |
|
|
2019
Q2 | $18.1M | Sell |
248,984
-20,200
| -8% | -$1.59M | 0.11% | 89 |
|
|
2019
Q1 | $21.7M | Buy |
269,184
+92,058
| +52% | +$7.53M | 0.13% | 80 |
|
|
2018
Q4 | $16.3M | Buy |
177,126
+17,390
| +11% | +$1.53M | 0.12% | 84 |
|
|
2018
Q3 | $15.1M | Buy |
159,736
+6,114
| +4% | +$580K | 0.09% | 96 |
|
|
2018
Q2 | $14.2M | Sell |
153,622
-438
| -0.3% | -$42.8K | 0.09% | 100 |
|
|
2018
Q1 | $14.6M | Sell |
154,060
-27,186
| -15% | -$2.99M | 0.09% | 96 |
|
|
2017
Q4 | $17.5M | Sell |
181,246
-62,297
| -26% | -$5.87M | 0.11% | 90 |
|
|
2017
Q3 | $21.6M | Buy |
243,543
+16,779
| +7% | +$1.28M | 0.14% | 73 |
|
|
2017
Q2 | $16.4M | Sell |
226,764
-5,051
| -2% | -$340K | 0.11% | 89 |
|
|
2017
Q1 | $15.1M | Buy |
231,815
+3,925
| +2% | +$247K | 0.1% | 91 |
|
|
2016
Q4 | $14.3M | Buy |
227,890
+5,524
| +2% | +$337K | 0.1% | 93 |
|
|
2016
Q3 | $14M | Sell |
222,366
-4,690
| -2% | -$304K | 0.1% | 87 |
|
|
2016
Q2 | $14.1M | Buy |
227,056
+14,632
| +7% | +$892K | 0.11% | 93 |
|
|
2016
Q1 | $12.1M | Buy |
212,424
+65,115
| +44% | +$3.63M | 0.09% | 96 |
|
|
2015
Q4 | $8.73M | Sell |
147,309
-9,351
| -6% | -$539K | 0.07% | 126 |
|
|
2015
Q3 | $8.52M | Buy |
156,660
+1,877
| +1% | +$122K | 0.07% | 123 |
|
|
2015
Q2 | $10.4M | Buy |
154,783
+17,592
| +13% | +$1.15M | 0.07% | 112 |
|
|
2015
Q1 | $8.03M | Buy |
137,191
+5,053
| +4% | +$305K | 0.06% | 139 |
|
|
2014
Q4 | $8.65M | Sell |
132,138
-35,441
| -21% | -$2.23M | 0.06% | 128 |
|
|
2014
Q3 | $9.68M | Sell |
167,579
-25,963
| -13% | -$1.44M | 0.06% | 123 |
|
|
2014
Q2 | $10.9M | Sell |
193,542
-2,638
| -1% | -$138K | 0.06% | 123 |
|
|
2014
Q1 | $10.1M | Sell |
196,180
-41,364
| -17% | -$2.09M | 0.06% | 130 |
|
|
2013
Q4 | $12.5M | Sell |
237,544
-11,482
| -5% | -$564K | 0.08% | 109 |
|
|
2013
Q3 | $11.1M | Sell |
249,026
-17,938
| -7% | -$795K | 0.07% | 109 |
|
|
2013
Q2 | $11M | Buy |
+266,964
| New | +$11.7M | 0.08% | 105 |
|
Other funds holding ABBV
CIBC Asset Management's ABBV Position: Q2 2026 in Review
CIBC Asset Management increased its AbbVie (ABBV) stake by 6.7% in Q2 2026, buying an estimated $10.1M and bringing the position to 747,319 shares worth $188M. The position accounts for 0.41% of the portfolio, ranked #51.
CIBC Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- CIBC Asset Management held 747,319 shares of AbbVie worth $188M as of Q2 2026.
- CIBC Asset Management bought 47,137 AbbVie shares in Q2 2026, an estimated $10.1M.
- AbbVie made up 0.41% of CIBC Asset Management's portfolio in Q2 2026, its #51 holding.
- CIBC Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.